Construction of an Imaging Centre of Excellence (ICE) at the new South Glasgow University Hospital
Lead Research Organisation:
University of Glasgow
Department Name: College of Medical, Veterinary, Life Sci
Abstract
The synergy between imaging and genomics technologies has been recognised as being an important driver to the future development of Stratified or Precision Medicine. The benefits of stratified medicine are now globally recognised, and Scotland is uniquely placed to capitalise on this potential, owing to its strong academic research base, advanced electronic health records within the NHS, and a strong industry presence in genomics, bioinformatics and diagnostics. The South Glasgow University Hospital represents an investment to Glasgow and Scotland in the region of £1Billion. When it opens in 2015, the new hospital will be the largest in Western Europe and will include maternity, paediatric and adult services on a single site. The Imagine Centre of Excellence (ICE), located at the new hospital, will uniquely accommodate a 7 Tesla MRI scanner together with other imaging modalities for clinical and research use, including 3T MRI and high resolution multi-slice CT, all networked and sharing staff with the large number of service scanners within the main hospital. This state-of-the-art equipment will be housed alongside clinical academic imaging specialists, NHS clinical physics expertise, innovation space for industry, and potential for expansion of precision medicine activities.The University of Glasgow led the development of the Scotland-wide £20M Stratified Medicine Scotland Innovation Centre (SMS-IC), which will be based adjacent to the ICE building. The co-location of ICE and SMS-IC will therefore provide significant added value to both centres.
The creation of an internationally competitive centre in medical imaging incorporating NHS, academic and industry partners will allow Glasgow to support a much greater volume and variety of clinical trials and translational development than currently, including the associated supply chain. The facility will be co-located alongside commercial, learning, research and clinical facilities, and will be accessible to industry partners and collaborators thus ensuring spin off benefits to the local Scottish company base of specialist CROs and other service providers.
The proposed facility will maximise and facilitate the economic impact from the clinical research excellence at the new South Glasgow University Hospital, and ensure the hospital site becomes a clinical research-driven UK exemplar of a Life Sciences cluster. As such, the proposal fully aligns with the Scottish Life Sciences Strategy and the facility will add significant value to existing assets in Scotland.
The creation of an internationally competitive centre in medical imaging incorporating NHS, academic and industry partners will allow Glasgow to support a much greater volume and variety of clinical trials and translational development than currently, including the associated supply chain. The facility will be co-located alongside commercial, learning, research and clinical facilities, and will be accessible to industry partners and collaborators thus ensuring spin off benefits to the local Scottish company base of specialist CROs and other service providers.
The proposed facility will maximise and facilitate the economic impact from the clinical research excellence at the new South Glasgow University Hospital, and ensure the hospital site becomes a clinical research-driven UK exemplar of a Life Sciences cluster. As such, the proposal fully aligns with the Scottish Life Sciences Strategy and the facility will add significant value to existing assets in Scotland.
Technical Summary
The synergy between imaging and genomics technologies has been recognised by the Technology Strategy Board as being an important driver to the future development of Stratified or Precision Medicine. The benefits of stratified medicine are now globally recognised, and Scotland is uniquely placed to capitalise on this potential, owing to its strong academic research base, advanced electronic health records within the NHS, and a strong industry presence in genomics, bioinformatics and diagnostics. The University of Glasgow led the development of the Scotland-wide £20M Stratified Medicine Scotland Innovation Centre (SMS-IC), which will also based at the South Glasgow University Hospital campus. The focus of SMS-IC is on bringing together genome sequencing technology and the complex bioinformatics required to link genomic data with NHS clinical data to allow stratification of patients based on genetic profiles. The co-location of ICE and SMS-IC will therefore provide significant added value to both centres.
By linking clinical academics, NHS and industry together, the Imaging Centre of Excellence (ICE) will maximise and facilitate the economic impact from the clinical research excellence at the new South Glasgow University Hospital, and ensure the hospital site becomes a UK exemplar of a Life Sciences cluster. As such, the proposal fully aligns with the Scottish Life Sciences Strategy and the facility would add significant value to existing assets in Scotland.
By linking clinical academics, NHS and industry together, the Imaging Centre of Excellence (ICE) will maximise and facilitate the economic impact from the clinical research excellence at the new South Glasgow University Hospital, and ensure the hospital site becomes a UK exemplar of a Life Sciences cluster. As such, the proposal fully aligns with the Scottish Life Sciences Strategy and the facility would add significant value to existing assets in Scotland.
Planned Impact
The ICE building is being designed to allow direct ambulatory access for patients, and the building will be linked to the new Clinical Research Facility to allow clinical trials to benefit from the advanced imaging technologies. The Glasgow MRI facility will offer a resource that will be uniquely valuable for researchers across the country, and central to its goals will be the application of advanced technology to understanding of human disease. The ability to undertake the most advanced imaging across the entire spectrum of clinical problems, encompassing acutely unwell or dependent patients, is a key principle of the research imaging facility.
Importantly, NHS Greater Glasgow & Clyde's catchment area covers a population of 2.8 million, and represents one of the most epidemiologically problematic areas of the UK including high co-morbidity and chronic disease. Therefore the clinical environment is certainly unique within the UK. Of course, for maximum clinical impact any imaging facility needs to be embedded within the hospital environment - so, for example, a 7T MRI scanner based in Oxford would not be of use to the large cohort of stroke patients in the West of Scotland. However, our ability to network with other 7T sites in the UK, as these develop, will contribute to the development of 7T skills, knowledge and expertise across the UK.
Ultimately the impact of ICE will extend to the whole patient population through the development of innovative diagnostics and medicines. It will also ensure that the new hospital becomes a UK exemplar for life sciences industry. NHS Greater Glasgow & Clyde already has the largest Clinical Physics NHS department in the UK and the largest imaging modality assets in Europe. The co-location of the Imaging Centre of Excellence will ensure the ability to recruit, train and retain the highest calibre of staff in diagnostic imaging, clinical physics and related disciplines. It will allow the hospital to provide unprecedented access to advanced diagnostic imaging for patients and greater access to advanced clinical research studies, including major international collaborations. We also anticipate that the co-location of ICE will attract specialist medical conferences to the hospital, and will also facilitate an entrepreneurial culture within the hospital to ensure the development and sustainability of NHS start-up companies.
Importantly, NHS Greater Glasgow & Clyde's catchment area covers a population of 2.8 million, and represents one of the most epidemiologically problematic areas of the UK including high co-morbidity and chronic disease. Therefore the clinical environment is certainly unique within the UK. Of course, for maximum clinical impact any imaging facility needs to be embedded within the hospital environment - so, for example, a 7T MRI scanner based in Oxford would not be of use to the large cohort of stroke patients in the West of Scotland. However, our ability to network with other 7T sites in the UK, as these develop, will contribute to the development of 7T skills, knowledge and expertise across the UK.
Ultimately the impact of ICE will extend to the whole patient population through the development of innovative diagnostics and medicines. It will also ensure that the new hospital becomes a UK exemplar for life sciences industry. NHS Greater Glasgow & Clyde already has the largest Clinical Physics NHS department in the UK and the largest imaging modality assets in Europe. The co-location of the Imaging Centre of Excellence will ensure the ability to recruit, train and retain the highest calibre of staff in diagnostic imaging, clinical physics and related disciplines. It will allow the hospital to provide unprecedented access to advanced diagnostic imaging for patients and greater access to advanced clinical research studies, including major international collaborations. We also anticipate that the co-location of ICE will attract specialist medical conferences to the hospital, and will also facilitate an entrepreneurial culture within the hospital to ensure the development and sustainability of NHS start-up companies.
Organisations
- University of Glasgow (Lead Research Organisation)
- UNIVERSITY OF OXFORD (Collaboration)
- Siemens Healthcare (Collaboration)
- UNIVERSITY OF NOTTINGHAM (Collaboration)
- MR CoilTech Ltd (Collaboration)
- Cardiff University (Collaboration)
- Canon (Collaboration)
- Nottingham University Hospitals NHS Trust (Collaboration)
- BioSpyder Technologies Inc (Collaboration)
- UNIVERSITY OF CAMBRIDGE (Collaboration)
Publications
Abdalrahaman N
(2015)
Deficits in Trabecular Bone Microarchitecture in Young Women With Type 1 Diabetes Mellitus.
in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Abdalrahaman N
(2017)
The relationship between adiposity, bone density and microarchitecture is maintained in young women irrespective of diabetes status
in Clinical Endocrinology
Abdalrahman N
(2015)
An update on diabetes related skeletal fragility.
in Expert review of endocrinology & metabolism
Abdul-Rahim A
(2016)
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
in European Heart Journal
Abdul-Rahim AH
(2015)
Associations of chronic heart failure with outcome in acute ischaemic stroke patients who received systemic thrombolysis: analysis from VISTA.
in European journal of neurology
Abdul-Rahim AH
(2015)
Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
in Circulation
Abdul-Rahim AH
(2016)
Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial.
in International journal of cardiology
| Description | Precision Medicine Innovation in Scotland: Accelerating Productivity Growth for Scotland and the UK Science and Innovation Audit Report sponsored by the Department for Business, Energy and Industrial Strategy March 2019 |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| URL | https://www.gla.ac.uk/media/Media_639152_smxx.pdf |
| Description | (PredAMEG) - Identifying Oscillatory Signatures of Predictive Coding in Hierarchical Auditory Networks with MEG |
| Amount | € 183,454 (EUR) |
| Funding ID | 708138 |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 01/2017 |
| End | 12/2018 |
| Description | As assessment of the relationships between global longitudinal strain and infarct characteristics in patients with recent non-ST elevation myocardial infarction |
| Amount | £2,000 (GBP) |
| Organisation | Medical Research Scotland |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 06/2016 |
| End | 07/2016 |
| Description | Bioimaging tools and resource development 7 Tesla MRI |
| Amount | £150,000 (GBP) |
| Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 07/2017 |
| End | 12/2018 |
| Description | CORonary MICrovascular Angina (CorMicA): A mechanistic pilot trial and nested MRI sub-study |
| Amount | £297,478 (GBP) |
| Funding ID | PG/17/25/32884 |
| Organisation | British Heart Foundation (BHF) |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2017 |
| End | 09/2020 |
| Description | CiC Validating Molecular Targets in the Vascular Pathophysiology of CADASIL |
| Amount | £91,560 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2017 |
| End | 02/2018 |
| Description | Development of an automated holistic brain MRI damage metric in stroke |
| Amount | £2,000 (GBP) |
| Organisation | Medical Research Scotland |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 07/2018 |
| End | 09/2018 |
| Description | ESPE Support for European Registries |
| Amount | £12,360 (CLF) |
| Organisation | European Society of Pediatric Endocrinology (ESPE) |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 02/2018 |
| End | 01/2019 |
| Description | Early diagnosis and intervention of osteoporosis using nanovibrational stimulation |
| Amount | £48,807 (GBP) |
| Funding ID | ST/S000852/1 |
| Organisation | Science and Technologies Facilities Council (STFC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2018 |
| End | 10/2020 |
| Description | European Registries For Rare Endocrine Conditions |
| Amount | £175,201 (GBP) |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 02/2018 |
| End | 01/2021 |
| Description | European Society of Endocrinology contribution for Year 1 of EuRRECa |
| Amount | £13,010 (GBP) |
| Organisation | European Society of Endocrinology |
| Sector | Learned Society |
| Country | European Union (EU) |
| Start | 01/2018 |
| End | 01/2019 |
| Description | Genotype and phenotype correlation in a CADASIL cohort and biomarker validation using 7 Tesla MRI |
| Amount | £150,000 (GBP) |
| Organisation | Scottish Neurological Research Fund |
| Sector | Academic/University |
| Start | 08/2019 |
| Description | Glasgow Children's Hospital Charity Research Fund |
| Amount | £37,593 (GBP) |
| Organisation | Glasgow Children's Hospital Charity |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 12/2018 |
| End | 11/2020 |
| Description | Human Brain Project |
| Amount | £487,239 (GBP) |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 04/2016 |
| End | 03/2018 |
| Description | Human Brain Project |
| Amount | £487,239 (GBP) |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 04/2016 |
| End | 03/2018 |
| Description | Human Brain Project SGA 2 |
| Amount | £1,191,606 (GBP) |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 01/2018 |
| End | 12/2022 |
| Description | Human Brain Project SGA 2 |
| Amount | £860,553 (GBP) |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 04/2018 |
| End | 03/2020 |
| Description | Hybrid 1H/19F Magnetic Resonance Imaging at 7T |
| Amount | £151,657 (GBP) |
| Funding ID | BB/P027385/1 |
| Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 07/2017 |
| End | 02/2019 |
| Description | I-CAIRD: Industrial Centre for AI Research in Digital Diagnostics |
| Amount | £1,915,331 (GBP) |
| Funding ID | 104690 |
| Organisation | Innovate UK |
| Sector | Public |
| Country | United Kingdom |
| Start | 12/2018 |
| End | 11/2021 |
| Description | Identifying neural signatures of auditory-predictive processing in schizophrenia: a multi-modal imaging approach |
| Amount | £1,114,545 (GBP) |
| Funding ID | MR/R011885/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 12/2019 |
| Description | Improving support for children with rare conditions in Glasgow. |
| Amount | £8,778 (GBP) |
| Organisation | Kyowa Hakko Kirin Company |
| Sector | Private |
| Country | Japan |
| Start | 08/2016 |
| End | 08/2019 |
| Description | Industrial Strategy Challenge Fund (ISCF) Data to Early Diagnosis and Precision Medicine Challenge |
| Amount | £6,271 (GBP) |
| Organisation | Health Data Research UK |
| Sector | Private |
| Country | United Kingdom |
| Start | 03/2019 |
| End | 11/2019 |
| Description | Ipsen industrial studentship - Investigation of nerve toxins for the control of pain after spinal cord injury |
| Amount | £210,000 (GBP) |
| Organisation | Ipsen |
| Sector | Private |
| Country | Global |
| Start | 12/2017 |
| End | 05/2021 |
| Description | MRC Neurosciences and Mental Health Board |
| Amount | £123,537 (GBP) |
| Funding ID | MR/N008537/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2016 |
| End | 12/2018 |
| Description | MRC STRATified MEDicine Initiative - Consortium Building Award |
| Amount | £15,000 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2017 |
| End | 11/2017 |
| Description | Magnetic resonance imaging to Assess Carotid-Brain interactions in people with stroke (MAC-Brain) |
| Amount | £37,500 (GBP) |
| Organisation | The Neurosciences Foundation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2018 |
| End | 09/2021 |
| Description | Mechanisms of neuropathic pain following spinal cord injury: role of the spinothalamic tract |
| Amount | £100,416 (GBP) |
| Organisation | The Inspire Foundation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2017 |
| End | 03/2021 |
| Description | Office for Rare Conditions Project |
| Amount | £75,000 (GBP) |
| Organisation | Glasgow Children's Hospital Charity |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 12/2018 |
| End | 11/2019 |
| Description | Pilot study of adaptive cognitive training for translation to neurological conditions |
| Amount | £4,800 (GBP) |
| Organisation | The Neurosciences Foundation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 02/2017 |
| End | 12/2017 |
| Description | Pilot study of adaptive cognitive training for translation to neurological conditions |
| Amount | £1,291 (GBP) |
| Organisation | Neuroscience Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 01/2018 |
| End | 05/2018 |
| Description | Probing the rheumatoid arthritis brain to expose central pain pathways |
| Amount | £365,636 (GBP) |
| Funding ID | 22453 |
| Organisation | Versus Arthritis |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 08/2020 |
| End | 07/2022 |
| Description | Rare disease office |
| Amount | £75,000 (GBP) |
| Organisation | Glasgow Children's Hospital Charity |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2017 |
| End | 11/2018 |
| Description | Rare disease office |
| Amount | £75,000 (GBP) |
| Organisation | Glasgow Children's Hospital Charity |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 10/2016 |
| End | 09/2017 |
| Description | SINAPSE Seed Fund Studentship "Developing an automated collateral scoring method for acute stroke" |
| Amount | £30,000 (GBP) |
| Organisation | Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE) |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 10/2016 |
| End | 09/2019 |
| Description | SINAPSE Seed Fund Studentship "Developing an automated collateral scoring method for acute stroke" |
| Amount | £30,000 (GBP) |
| Organisation | Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE) |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 10/2016 |
| End | 09/2019 |
| Description | Stroke/Imaging Block Award |
| Amount | £40,000 (GBP) |
| Organisation | RS Macdonald Charitable Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2018 |
| End | 02/2019 |
| Description | Supplementary Funding for ICE |
| Amount | £90,389 (GBP) |
| Organisation | Chief Scientist Office |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2018 |
| End | 03/2021 |
| Description | TNF-alpha antagonism and brain monocyte recruitment in sickness behaviour in rheumatoid arthritis |
| Amount | £1,497,830 (GBP) |
| Funding ID | MR/S035753/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2019 |
| End | 08/2022 |
| Description | The Precision Medicine Ecosystem |
| Amount | £3,480,000 (GBP) |
| Organisation | Government of Scotland |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2016 |
| End | 03/2017 |
| Description | The T-TIME trial coronary physiology study |
| Amount | £263,332 (GBP) |
| Funding ID | FS/16/74/32573 |
| Organisation | British Heart Foundation (BHF) |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2017 |
| End | 04/2020 |
| Description | The UK7T Network: developing the ultra-high field MRI platform for biomedical research. |
| Amount | £1,050,149 (GBP) |
| Funding ID | MR/N008537/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2016 |
| End | 03/2019 |
| Description | The conundrum of angina in patients without obstructive coronary disease as revealed by CT coronary angiography (COR-CTCA): an observational cohort study involving coronary function tests and a nested randomised trial |
| Amount | £283,092 (GBP) |
| Funding ID | FS/17/26/32744 |
| Organisation | British Heart Foundation (BHF) |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 08/2017 |
| End | 07/2020 |
| Description | Translational Research Initiative |
| Amount | £1,000,000 (GBP) |
| Funding ID | MC_PC_18048 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 07/2019 |
| End | 03/2021 |
| Description | UNDER THE CONNECTING EUROPE FACILITY (CEF) - TELECOMMUNICATIONS SECTOR |
| Amount | £28,062 (GBP) |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 07/2018 |
| End | 09/2019 |
| Description | Using Magnetoencephalography to Investigate Aberrant Neural Synchrony in Prodromal Schizophrenia: A Translational Biomarker Approach |
| Amount | £816,354 (GBP) |
| Funding ID | MR/L011689/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 07/2014 |
| End | 02/2019 |
| Description | Whole brain Human Ischaemic Stroke Perfusion and Extended Re-canalisation (WHISPER) -Pilot Study |
| Amount | £9,600 (GBP) |
| Organisation | The Neurosciences Foundation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2017 |
| End | 03/2019 |
| Description | Whole-brain Human Ischaemic Stroke Perfusion and Extended Re-canalisation Study (WHISPER) |
| Amount | £299,934 (GBP) |
| Organisation | Chief Scientist Office |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2018 |
| End | 08/2020 |
| Description | YCC Research Support Scheme |
| Amount | £63,092 (GBP) |
| Organisation | Glasgow Children's Hospital Charity |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2016 |
| End | 11/2018 |
| Description | BioClavis |
| Organisation | BioSpyder Technologies Inc |
| Country | United States |
| Sector | Private |
| PI Contribution | Using clinical samples obtained in the ORBIT trail, the research team generated the initial bioinformatic signatures (from RNAseq data) that were able to stratify rheumatoid arthritis patients into responders and non-responders to biological therapies. This enable the research team to create a new gene list for testing in the BioSpyder TempO-seq platform. |
| Collaborator Contribution | BioSpyder have been able to work in parallel with the research team to design an appropriate TempO-seq assay. The rationale for this is that to translate our initial bioinformatic signatures into a useful clinical test requires us to use a assay that has the potential to be used in the clinic. The TempO-seq assay has this potential. |
| Impact | No output or outcomes to date, as the study is still on-going. |
| Start Year | 2017 |
| Description | Canon - enabling multidisciplinary collaboration |
| Organisation | Canon |
| Department | Canon Medical Research Europe |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Access to academics, clinical academics, clinicians to shape research collaborations and identify new opportunities. Access to imaging facilities within ICE. |
| Collaborator Contribution | Access to technical and commercial expertise, training of students and staff. |
| Impact | Further research opportunities have been identified and funding pursued. |
| Start Year | 2018 |
| Description | MRCoiltech - coil development and commercialisation |
| Organisation | MR CoilTech Ltd |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | A group of researchers focussed on coil development, data capture and analysis/interpretation are working together with MRCoiltech to develop and commercialise new body coils for 7T scanners. In addition to the contributions made by the academics involved in the collaboration the centre provides MRCoiltech with access to RF coil lab and scanner for safety testing and validation of the technologies being developed. |
| Collaborator Contribution | MRCoiltech provide technical know-how and expertise and provide training. MRCoiltech provides the vehicle by which the coils developed will be commercialised and taken to market. This includes clinical proof of concept, quality assurance and regulatory compliance. |
| Impact | This collaboration has enabled further research opportunities to be identified and funding to be sought. |
| Start Year | 2018 |
| Description | Siemens - co-development of 7T scanner |
| Organisation | Siemens Healthcare |
| Country | Germany |
| Sector | Private |
| PI Contribution | A group of researchers focussed on coil development, data capture and analysis/interpretation are working together with Siemens to support the clinical application of the 7T scanner. |
| Collaborator Contribution | Siemens have embedded a senior technician within the research team at Glasgow to support the development of new tools and technologies. Additional technical support is provided by colleagues based In Germany. |
| Impact | A new separate research collaboration has evolved from this collaboration. |
| Start Year | 2018 |
| Description | Siemens - optimisation and evaluation of image quality and examination workflow of head and knee coils in the 7T MRI magentom terra |
| Organisation | Siemens Healthcare |
| Country | Germany |
| Sector | Private |
| PI Contribution | Access to expertise, volunteers and facilities. |
| Collaborator Contribution | Access to technical expertise and equipment. |
| Impact | n/a |
| Start Year | 2019 |
| Description | UK7T Imaging Network: developing the ultra-field MRI platform for biomedical research. |
| Organisation | Cardiff University |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We are a founder member of the Network. |
| Collaborator Contribution | We have been integral to the planning and governance of the Network. |
| Impact | There are no outcomes to report at this time. The collaboration is multi-disciplinary - neuroscience; psychology; cardiovascular; imaging; electronics; informatics. |
| Start Year | 2016 |
| Description | UK7T Imaging Network: developing the ultra-field MRI platform for biomedical research. |
| Organisation | Nottingham University Hospitals NHS Trust |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We are a founder member of the Network. |
| Collaborator Contribution | We have been integral to the planning and governance of the Network. |
| Impact | There are no outcomes to report at this time. The collaboration is multi-disciplinary - neuroscience; psychology; cardiovascular; imaging; electronics; informatics. |
| Start Year | 2016 |
| Description | UK7T Imaging Network: developing the ultra-field MRI platform for biomedical research. |
| Organisation | University of Cambridge |
| Department | Wolfson Brain Imaging Centre |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We are a founder member of the Network. |
| Collaborator Contribution | We have been integral to the planning and governance of the Network. |
| Impact | There are no outcomes to report at this time. The collaboration is multi-disciplinary - neuroscience; psychology; cardiovascular; imaging; electronics; informatics. |
| Start Year | 2016 |
| Description | UK7T Imaging Network: developing the ultra-field MRI platform for biomedical research. |
| Organisation | University of Nottingham |
| Department | School of Physics and Astronomy |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We are a founder member of the Network. |
| Collaborator Contribution | We have been integral to the planning and governance of the Network. |
| Impact | There are no outcomes to report at this time. The collaboration is multi-disciplinary - neuroscience; psychology; cardiovascular; imaging; electronics; informatics. |
| Start Year | 2016 |
| Description | UK7T Imaging Network: developing the ultra-field MRI platform for biomedical research. |
| Organisation | University of Oxford |
| Department | Division of Clinical Neurology |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We are a founder member of the Network. |
| Collaborator Contribution | We have been integral to the planning and governance of the Network. |
| Impact | There are no outcomes to report at this time. The collaboration is multi-disciplinary - neuroscience; psychology; cardiovascular; imaging; electronics; informatics. |
| Start Year | 2016 |
| Title | New MRI Coil design |
| Description | As part of the Imaging Centre of excellence funding new MRO coil development group has been established under direction of Dr Shajan Gunomany which has developed a novel new coil for the Siemens MRI systems with enhanced channel numbers and imaging capability. |
| Type | Diagnostic Tool - Imaging |
| Current Stage Of Development | Initial development |
| Year Development Stage Completed | 2017 |
| Development Status | Under active development/distribution |
| Impact | This has helped establish both the academic research capability in this area and supported establishment of a medical devices SME onsite. |
| Title | New MRI Coil design |
| Description | As part of the Imaging Centre of excellence funding new MRO coil development group has been established under direction of Dr Shajan Gunomany which has developed a novel new coil for the Siemens MRI systems with enhanced channel numbers and imaging capability. |
| Type | Diagnostic Tool - Imaging |
| Current Stage Of Development | Refinement. Non-clinical |
| Year Development Stage Completed | 2018 |
| Development Status | Under active development/distribution |
| Impact | This is an highly novel experimental coil design developed as part of the Imaging Centre of Excellennce |
| Description | Tim Sheppard General Manager UK & Ireland, QuintilesIMS |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Facility Tour and discussion of potential collaborations |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://www.iqvia.com/ |
| Description | "Innovation for Collaboration" Industry Day - 2018 |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Objectives: • To showcase the University of Glasgow's innovation activities and provide Innovate with a platform to launch Scotland's engagement with the Industrial Challenge Strategy Fund • To broker introductions between academics, industry and NHS through facilitated workshops and match making • 155 delegates attended (89 academic, 66 NHS and Industry) • 4 Interactive workshop sessions including 2 tailored around identified training needs and opportunities for collaboration • Provided a forum for engagement of industry with Scotland's BEIS Science and Innovation Audit on Precision Medicine • One attending SME has re-located to Glasgow's Clinical Innovation Zone and partnered with the University to bring an international IEEE Conference on "Blockchain for Clinical Trials" to Glasgow - attracting 170 registered attendees. Industry Day Workshop "Industrial Strategy Challenge Fund - Developing Connections" Objectives: • To provide an overview of the Industrial Challenge Strategy Fund, in particular the 'Data to early diagnosis and precision medicine challenge'. • The opportunity to present Offers (e.g. expertise, technologies, approaches, cohorts, infrastructure) to enable identification and development of potential consortia to apply for ISCF funding. • The opportunity to identify specific Needs (e.g. skills, products, expert advice, access to data, samples etc) to support current activities/potential consortia aligned with ISCF funding opportunities. • The opportunity to meet and talk with partners from different sectors, and consider potential collaborative funding bids. Outcomes • Needs and offers presented by 20 participants facilitating discussion and further networking • A pan Scotland consortium was established and successfully bid for the ISCF Centres of Excellence in Digital Pathology and Radiology - resulting in £15M of funding for a consortium of 17 partners from Industry, NHS and Academia. |
| Year(s) Of Engagement Activity | 2015,2018 |
| Description | 7 Tesla International Seminar series 2016-17 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | This is an International seminar series has been launched to foster multidisciplinary relationships between scientists and clinicians, further facilitate translational clinical research, and promote the development of 7T both in Glasgow and on the international stage. This programme is open to staff and students alike, as well as our NHS and industry partners and members of the public. This program has been run from September 2016 and has been well attended through the standing ad quality of the national and international speakers. |
| Year(s) Of Engagement Activity | 2016,2017 |
| URL | http://www.gla.ac.uk/colleges/mvls/ice/seminars/#/previousseminars |
| Description | 7T MRI access event 09/10/17 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Event to showcase and introduce 7T MRI scanner organised by SINAPSE Imaging network |
| Year(s) Of Engagement Activity | 2017 |
| Description | Alison MacEwan & Sara Cebrian, Foreign & Commonwealth Office |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Raising government awareness of clinical innovation zone, Queen Elizabeth campus and ICE |
| Year(s) Of Engagement Activity | 2016 |
| Description | Alumni Tour |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Other audiences |
| Results and Impact | Tour of ICE building for MVLS alumni |
| Year(s) Of Engagement Activity | 2017 |
| Description | BBSRC Visit 20/07/17 |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Regular site visit by BBSRC to review research supported - tour of ICE and innovation facilities included |
| Year(s) Of Engagement Activity | 2017 |
| Description | BIOCON visit J & K Shaw |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Visit by BIOCON group (India Pharma) to gain insight into capabilities of ICE |
| Year(s) Of Engagement Activity | 2017 |
| Description | Bayer : Richard Condon and John McCann |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Showcase of ICE and strategic discussions |
| Year(s) Of Engagement Activity | 2017 |
| Description | Blackford scientific meeting/Andrew Fowlie Scottish Govt. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Industry/Business |
| Results and Impact | Technical meeting with Blackford (SMS) NHS and ICE to discuss Innovate UK grant application |
| Year(s) Of Engagement Activity | 2017 |
| Description | British Heart Foundation Visit |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | BHF delegation visit to review research in cardiovascular research and first sight of new ICE facilities |
| Year(s) Of Engagement Activity | 2017 |
| Description | CEO Inovate UK visit - Dr Ruth Mckernan |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Visit and tour of ICE by Ruth McKernand with strategic discussions on future engagement of ICE and Stratified Medicine Scotland in Precision Medicine |
| Year(s) Of Engagement Activity | 2017 |
| Description | CRUk trustees |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Third sector organisations |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2019 |
| Description | Calum MCrae - Precision medicine event |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Industry/Business |
| Results and Impact | A presentation and panel discussion regarding precision medicine opportunities |
| Year(s) Of Engagement Activity | 2019 |
| Description | Causeway Theraputics |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Industry/Business |
| Results and Impact | Initial discussion of tenancy in ICE |
| Year(s) Of Engagement Activity | 2017 |
| Description | College of Medical Veterinary & Life Sciences Industry Day 2015 |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | There were 311 delegates attended an all-day event focused on bringing together academia and the biomedical and life sciences industry with a focus on precision medicine. The event comprised a series of lectures and workshops including a panel discussion featuring the Imaging Centre of Excellence and its importance in precision medicine. |
| Year(s) Of Engagement Activity | 2015 |
| Description | Dean Chong |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2019 |
| Description | Delivery of 7 Tesla MRI Scanner Queen Elizabeth University Hospital November 2016. This was a significant event widely covered in the local press and TV and attended by all academic NHS Industry and funding partners involved in this project. It gained extensive impact and discussion in the local press in the subsequent days. |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Public/other audiences |
| Results and Impact | The principal objectives of this event were to leverage the press coverage around this event to raise the profile of the ICE centre of excellence at a national level and also to acknowledge the contributions of the key partners in this event. The physical installation of the 7 Tesla scanner was a dramatic event and gained extensive TV and press coverage in Scottish TV stations and the regional press. In terms of raising the profile of the regard the event has been an outstanding ICE centre and by extension the wider Queen Elizabeth University Hospital including our clinical innovation zone. |
| Year(s) Of Engagement Activity | 2016 |
| URL | http://www.gla.ac.uk/news/archiveofnews/2016/december/headline_501585_en.html |
| Description | Department for International Trade (DIT) visit Marion Francis 05/07/17 |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Tour and raising awareness of ICE and campus facilities in the context of identifying new investment opportunities with DIT |
| Year(s) Of Engagement Activity | 2017 |
| Description | Doseme visit |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Industry/Business |
| Results and Impact | Tour as potential tenants of ICE |
| Year(s) Of Engagement Activity | 2017 |
| Description | Dr Barbara Blaney, Medicity |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Industry/Business |
| Results and Impact | Visit and presentation of ICE and Clinical Innovation zone plans to key management of local Medtech incubator group Medicity. |
| Year(s) Of Engagement Activity | 2016 |
| Description | Dr Chris Gray Michigan University |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Visit and tour of facilities and scientific discussion. |
| Year(s) Of Engagement Activity | 2017 |
| Description | Dr Mene Pangalos AZ |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Visit for award of Honorary Degree and discussions regarding future collaborations with AZ |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://www.astrazeneca.com/media-centre/articles/2017/mene-pangalos-awarded-honorary-doctor-of-scie... |
| Description | Dr Mohammed Al Redha visit Dubai Health Authority |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Visit to develop links to raise profile of ICE project and develop collaborative projects with Dubai Health Authority |
| Year(s) Of Engagement Activity | 2017 |
| Description | Emily Jefferson |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2019 |
| Description | Euan Dick |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2020 |
| Description | European Society for Radioteherapy and Oncology visir |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Tour of facilities and event In ICE - ESTRO annual conference is now committed to Glasgow SEEC for 3 years. |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://www.estro.org/ |
| Description | Forensic Mortuary Rapid Improvement event |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Professional development event held in ICE developing collaborative links with Forensic Pathologists |
| Year(s) Of Engagement Activity | 2017 |
| Description | Formal opening of Imaging Centre of Excellence and Industry day event |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Major launch event tied to College Industry day |
| Year(s) Of Engagement Activity | 2010,2017 |
| URL | https://www.gla.ac.uk/colleges/mvls/industryday2017/ |
| Description | GSK Visit Malcolm Skingle |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Tour of facilities and contribution to College educational MOOC |
| Year(s) Of Engagement Activity | 2017 |
| Description | Gideon Ho HistoIndex Cllinovate UK |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Follow up discussion of Singapore visit and also SME tenancy |
| Year(s) Of Engagement Activity | 2017 |
| Description | Glasgow Science Centre Meeting |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Public/other audiences |
| Results and Impact | Opening up dialogue and collaboration with Glasgow Science Centre such student presentations |
| Year(s) Of Engagement Activity | 2017 |
| Description | Graeme Reid - Visit to ICE |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Other audiences |
| Results and Impact | A tour of the academic infrastructure for innovation and collaboration at ICE and the QEUH campus. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Harper Van Steenhouse Biclavis |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Detailed discussions of tenancy within wider clinical innovation zone |
| Year(s) Of Engagement Activity | 2017 |
| Description | Harper VanSteenhouse, Director Biospyder California |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Visit and strategic discussion regarding opening of Biospyder presence within Clinical Innovation Zone and interaction with ICE |
| Year(s) Of Engagement Activity | 2016 |
| Description | High Commisioner India |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Visit and tour of facilities India HC |
| Year(s) Of Engagement Activity | 2017 |
| Description | Hitachi Healthcare visit 30/06 |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Visit and tour of Hitachi Healthcare in concert with Scottish Development International |
| Year(s) Of Engagement Activity | 2017 |
| Description | Human Brian Project |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | This is the showcase meeting of a major European Initiative which attracted hundreds of delegates interacted widely with the general public in Glasgow through multiday event held and activities held in Glasgow. This was lead by Professor L Muckli and a major reason for attracting event to Glasgow was ICE investment. |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://www.humanbrainproject.eu/en/follow-hbp/news/5th-annual-human-brain-project-summit/ |
| Description | IAVI (International AIDS Vaccine Initiative) |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Detailed Discussion regarding future collaboration and raising awareness of clinical innovation zone capabilities including imaging |
| Year(s) Of Engagement Activity | 2016 |
| Description | IBM |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Industry/Business |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2019 |
| Description | Imaging Cente of Excellence : Project planning day and workshops Feb 2017 |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Project planning and development day The purpose of this all day event was to bring together all of the internal and external stakeholders connected to and active in the delivery of the Imaging centre of excellence objectives. This comprised a selective group of academic NHS industry support staff with an active presence from the City of Glasgow. The day opened with an overview of the vision for ICE from industry partners Siemens and Professor David Porte, newly appointed Chair of MRI Physics. It then split into sub groups aligned specifically with the delivery work streams of the project encompassing the scientific and economic delivery work-streams with the overall ICE project plan. These engaged with a wider group of prospective users and advisors and addressed and stress tested a wide variety of issues related to delivery (technical issues, public engagement, industry partners, risk analysis etc). These sessions were moderated by an external facilitator and the results collated and will into a significant revision of the on going ICE delivery plan to be presented to the Board April 17. |
| Year(s) Of Engagement Activity | 2017 |
| Description | InnovateUK - Penny Wilson |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2019 |
| Description | Inspiring City Awards nomination |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Nomination and attendance at Inspiring cities award event |
| Year(s) Of Engagement Activity | 2017 |
| Description | Intel visit - |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | First meeting with senior technical staff Intel C Rhodes and C Emerson to showcase facilities (Genomics Pathology and Imaging) and to discuss future strategic collaborations |
| Year(s) Of Engagement Activity | 2017 |
| Description | Internaltional Imaging Symposium event 28/03/17 |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Major international Imaging event associated with formal opening of the Imaging Centre of Excellence |
| Year(s) Of Engagement Activity | 2017 |
| Description | Interview with Evening Times |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Interview in local Glasgow paper describing impact of ICE and new facilities on Queen Elizabeth University Hospital campus |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://www.eveningtimes.co.uk/news/15287964.Pioneering_expert_puts_Glasgow_at_the_cutting_edge_of_gl... |
| Description | JOhn Gilhooly |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Industry/Business |
| Results and Impact | Visit by John Gilhooly - consultant and investor in Par Equity - tour of facilities |
| Year(s) Of Engagement Activity | 2017 |
| Description | Joe Manning, Scottish Government, Cities & Local Growth Unit, Innovation Team + other representatives - |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Meeting with UK government representatives to update on ICE in context of City Region City deal |
| Year(s) Of Engagement Activity | 2016 |
| Description | John McCafferty, CEO Iontas |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Tour of facility and discussions of future collaboration with CEO of drug discovery company Iontas |
| Year(s) Of Engagement Activity | 2017 |
| Description | Joint meeting of the Association of British Pharmaceutical Industry and the Chief Scientist Office, Scotland. |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Industry/Business |
| Results and Impact | This meeting was to make the Association of British Pharmaceutical Industry aware of major research initiatives in precision medicine and imaging in Scotland and to discuss the mechanisms for deeper engagement with the pharmaceutical industry in the UK. |
| Year(s) Of Engagement Activity | 2016 |
| Description | Joyce Bowes, Senior OD Advisor - PPSU and Diagnostics |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Technical discussion NHS Imaging |
| Year(s) Of Engagement Activity | 2017 |
| Description | Julia Angeles, Diane Esson and John MacDougall, Baillie Gifford visit |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Industry/Business |
| Results and Impact | Visit and tour of facilities by Bailie Gifford Investment staff |
| Year(s) Of Engagement Activity | 2017 |
| Description | Kenny Simmen, Janssen Research & Development |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Visit and tour of Clinical Innovation Zone facilities leading to strategic discussion around long term collaboration including Imaging as stratification tool |
| Year(s) Of Engagement Activity | 2016 |
| Description | Kevin Rush & Anne Murray - Glasgow City Council |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Visit and presentation of Clinical Innovation zone and update on delivery plan for ICE with CITY Council as key partners in the City Region City Deal. |
| Year(s) Of Engagement Activity | 2016 |
| Description | Launch of dedicated webpage |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Launch of dedicated webpage for Imaging Centre of Excellence as portal to general public |
| Year(s) Of Engagement Activity | 2016 |
| URL | http://www.gla.ac.uk/colleges/mvls/ice/ |
| Description | Lena Wilson & Linda Hanna - Scottish Enterprise |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | In depth presentation of ICE to CEO of Scottish Enterprise leading to development of strategic engagement to support commercialisation activities in Clinical Innovation Zone through appointment of new business development manager. |
| Year(s) Of Engagement Activity | 2017 |
| Description | Linda Hanna, Julia Brown and Neil Guthrie - Scottish Enterprise - tour of all facilities including ICE |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Tour of facility and discussion of strategic engagement with Scottish Economic development agencies |
| Year(s) Of Engagement Activity | 2016 |
| Description | Lord Duncan Parliamentary Under Secretary of State for Scotland |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Visit and tour of facilities discussion of strategic engagement with Government in context of City Region City Deal Funding and other opportunities |
| Year(s) Of Engagement Activity | 2017 |
| Description | Louise Wood |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2019 |
| Description | MBA student visit |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Postgraduate students |
| Results and Impact | A presentation focussed on the economic opportunities offered by precision medicine followed by a tour of the facilities and infrastructure to demonstrate the facilities available for companies to engage with. |
| Year(s) Of Engagement Activity | 2020 |
| Description | MP Robin Walker (Parliamentary Under Secretary of State at the Department of Exiting the European Union) |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Tour of facilities and raising awareness with local MP with European brief |
| Year(s) Of Engagement Activity | 2017 |
| Description | MRC delegation 16/10/17 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | MRC Visit to review research programmes |
| Year(s) Of Engagement Activity | 2017 |
| Description | MSPs visit to Imaging Centre of Excellence Feb 2017 |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | This visit hosted by Professor Dominiczak and welcomed senior Scottish Government Ministers Shona Robison MSP and Michael Russell MSP to the new Imaging Centre of Excellence in early February 2017. Ms Robison, the Scottish Government Cabinet Secretary for Health, and Mr Russell, the Minister for UK Negotiations on Scotland's Place in Europe, first met with Vice Principal and Head of College, Professor Dame Anna Dominiczak, and were then given a tour of ICE by Dr Carol Clugston, the Chief Operating Officer of MVLS.The MSPs were also there to discuss the potential difficulties posed by Brexit and the implications for the NHS and EU funding for NHS and research collaborations. The visit provided and excellent opportunity to impress upon these senior policy makers the long term vision and impact of the ICE project and influence policy at a Scottish Government level. |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://www.gla.ac.uk/colleges/mvls/ice/news/headline_512661_en.html |
| Description | Mahidol University visit , Thailand - |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Presentation of Queen Elizabeth University Campus and future plans for Clinical Innovation Zone including ICE |
| Year(s) Of Engagement Activity | 2016 |
| Description | Matthew Speers, CEO, Life Sciences, Department of International Trade |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Presentation of strategic plans for development of Queen Elizabeth University Hospital Campus including ICE |
| Year(s) Of Engagement Activity | 2016 |
| Description | Medgenome visit : Lakshmi Santhosh & Michael Nemzek |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Visit and scientific discussions with senior representative MedGenome |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://www.medgenome.com/ |
| Description | Medicity MOU |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Industry/Business |
| Results and Impact | Signing of MOu for collaboration within and beyond City Region City Deal with Medicity Scotland - part of the BioCity Group |
| Year(s) Of Engagement Activity | 2017 |
| Description | Meeting with Nadeem Sarwar organised Health |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Meeting to raise awareness of Imaging centre of excellence |
| Year(s) Of Engagement Activity | 2017 |
| Description | Milltrust International Group |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Other audiences |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2020 |
| Description | Ministerial visit - Imaging Centre of Excellence (ICE) Breaking-ground Ceremony |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | We hosted the Minister for Universities and Science, Jo Johnson for a 'Breaking-ground' Ceremony for the new Imaging Centre of Excellence. The day included a series of scientific and commercial presentation appraising the Minister of the significance of the new Centre in imaging and precision medicine. |
| Year(s) Of Engagement Activity | 2015 |
| Description | Molecular Pathology Node Forum |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | This event is listed under Molecular Pathology Node return but there was significant crossover in relation to future planning with ICE. |
| Year(s) Of Engagement Activity | 2017 |
| Description | Narenda Chirmule - visit |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Third sector organisations |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2019 |
| Description | Neil Guthrie/Andrea Taylor/Ed Hutchison, Scottish Enterprise |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Visit and future planning meeting senior managers in Scottish Enterprise |
| Year(s) Of Engagement Activity | 2016 |
| Description | Organisation for Human Brain Mapping |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2019 |
| Description | Pathology Rapid Improvement Event Meeting |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Professional development of Pathologists |
| Year(s) Of Engagement Activity | 2017 |
| Description | Patrick Chinnery |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Third sector organisations |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2020 |
| Description | Patrick Valance |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2020 |
| Description | Paul Drabwell |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2019 |
| Description | Paul Lewis/Neil Francis - Scottish Enterprise - tour of QEUH |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Early update and awareness raising with senior Scottish Enterprise management in the initial phase of ICE planning |
| Year(s) Of Engagement Activity | 2016 |
| Description | Professor Cathie Sudlow UK Biobank |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Facility tour and strategic discussions regarding pan UK biobanks |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://www.ukbiobank.ac.uk/ |
| Description | Professor Fiona Gilbert Cambridge University |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Visit by distinguished radiologist to ICE to see facilities and discuss potential collaborations |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://radiology.medschl.cam.ac.uk/about-us/departmental-staff/academic-staff/professor-fiona-j-gilb... |
| Description | Promoting partnerships - PRecision diagnOstics: MOlecular and imagING' |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Regular scientific review and Outreach meeting for MRC pathology node |
| Year(s) Of Engagement Activity | 2017 |
| Description | Quotient SDI visit 11/07/17 |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Visit of Quotient Biosciences management - in collaboration with SDI to see facilities and as potential long term tenants |
| Year(s) Of Engagement Activity | 2017 |
| Description | Roche Diagnostics Visit |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Visit and tour of facilities to senior representatives - mainly genomics and pathology oriented but cross references to ICE |
| Year(s) Of Engagement Activity | 2017 |
| Description | Rose Marie Robertson CSO American Heart Association |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Visit to facilities and technical scientific discussions. |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://professional.heart.org/professional/ResearchPrograms/A-TRAC/UCM_462375_Meet-the-Team.jsp |
| Description | Russel Group CEO visit |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Visit of Tim Bradshaw - tour of facilities and strategic discussion of linkage to Russell group strategy |
| Year(s) Of Engagement Activity | 2017 |
| Description | SDI Asia Pac Induction |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | An introduction to the research expertise and facilities at ICE and the QEUH campus to raise awareness and facilitate international collaborations. |
| Year(s) Of Engagement Activity | 2019 |
| Description | SINPASE meeting |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Meeting of SINAPSE group in ICE to discuss new approached to commercialisation - leading to market research funding application |
| Year(s) Of Engagement Activity | 2017 |
| Description | STEM teacher placement |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities and introduction to breadth of careers offered by precision medicine. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Scottish Science Park Managers Meeting |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Industry/Business |
| Results and Impact | Visit and tour of other Scottish Science park managers to show case ICE and other facilities |
| Year(s) Of Engagement Activity | 2017 |
| Description | Shirley-Anne Somerville MSP visit 26/04/17 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Raising awareness of ICE with MSP |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://www.gla.ac.uk/colleges/mvls/newsandevents/mvlsnewsletters/summer2017/headline_541449_en.html |
| Description | Shona Robison Cabinet Secretary for Health & Sport |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Visit by Cabinet Secretary for Health & Sport to see facilities and discuss future strategy |
| Year(s) Of Engagement Activity | 2017 |
| Description | Sinclair Dunlop, Epidarex Capital |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Industry/Business |
| Results and Impact | Tour of facilities and discussion of future investment opportunities with CEO of local strategic VC group |
| Year(s) Of Engagement Activity | 2017 |
| Description | Singapore Business Development |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Follow up from visit of Singapore High Commissioner in March |
| Year(s) Of Engagement Activity | 2017 |
| Description | Spiritus Susan Ramonat |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Industry/Business |
| Results and Impact | Initial discussions regarding tenancy in ICE. |
| Year(s) Of Engagement Activity | 2017 |
| URL | https://www.spirituspartners.com/ |
| Description | TATA Consulting group visit |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Detailed tour of ICE facilities from Tata Consultancy Services - raising awareness - lead directly to interaction between Kvatchii (SME) and TCS |
| Year(s) Of Engagement Activity | 2017 |
| Description | Taiwan delegation visit |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Visit and tour of facilities Taiwan Industry and policy delegation |
| Year(s) Of Engagement Activity | 2017 |
| Description | The Dr Mortimer And Theresa Sackler Foundation visit |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Third sector organisations |
| Results and Impact | Tour of facilities and presentation to Dame Sackler and other senior trustees and management of Sackler Foundation the major charitable donor to ICE. |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://beta.charitycommission.gov.uk/charity-details/?subid=0®id=1128926 |
| Description | The Global Game Changers Awards |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | ICE related nominations and attendance at local award event |
| Year(s) Of Engagement Activity | 2017 |
| Description | The Scotsman Life Sciences Conference |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Sponsorship of event by University including highlighting ICE activity |
| Year(s) Of Engagement Activity | 2017 |
| Description | Tim Cook, CEO, Apple - tour of all facilities including ICE |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Visit to ICE Integrated with award of Honorary degree to Tim Cook CEO of Apple. There was particular discussion on potential future collaboration on digital technology pertaining to both Imaging applications, Stratified Medicine and health tracking technology. |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://www.gla.ac.uk/myglasgow/news/archives/2017/february/headline_513206_en.html |
| Description | UESTC president |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2019 |
| Description | Universits 21 |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Visit and awareness raising - reference to ICE as new facility for training of exchange students in the U"1 network |
| Year(s) Of Engagement Activity | 2017 |
| Description | UoG/NHS GG&C PRE START WORKSHOP |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Workshop bringing together all future users of ICE facility for planning and strategy development |
| Year(s) Of Engagement Activity | 2017 |
| Description | UofG MBNA student visit to ICE |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Postgraduate students |
| Results and Impact | This lecture focussed on the commercial and economic opportunities that precision medicine offers. A tour of the facilities was included so that the students could learn about the ways in which ICE collaborates with companies. |
| Year(s) Of Engagement Activity | 2019 |
| Description | Victor Dzau |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Significant presentations and planning with key US opinion leader and policy influencer in US government. |
| Year(s) Of Engagement Activity | 2016 |
| Description | Viramatix |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Industry/Business |
| Results and Impact | Visit and tour for SME company as potential ICE tenants |
| Year(s) Of Engagement Activity | 2017 |
| URL | http://viramatix.com/#aboutUs |
| Description | Visif of Angus Lamond University of Dundee |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Discussion on closer links between University Dundee cell based imaging Mas spec and ICE |
| Year(s) Of Engagement Activity | 2017 |
| Description | Visit by G Disley MD Cerno Health |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Visit by and Scientific presentation Mt Gary Disley MD Cerno Health 0 UK partner to Chinese Imaging company United Imaging - this is being followed up by visit within Industry day late March 2017 |
| Year(s) Of Engagement Activity | 2016 |
| Description | Visit by Tantaya Corp US |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Introduction to ICE project to prospective tenant in the Clinical Innovation Zone |
| Year(s) Of Engagement Activity | 2016 |
| Description | Visit of John Stageman University of Manchester |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Discussion of partnership with University of Manchester |
| Year(s) Of Engagement Activity | 2017 |
| Description | Visit of Korean Delegation |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | Visit of Korean Industry and academic delegation |
| Year(s) Of Engagement Activity | 2017 |
| Description | Visit of the First Minister of Scotland. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Policymakers/politicians |
| Results and Impact | The purpose of this visit was to update the First Minister on the University of Glasgow's developments and research and clinical strategy at the Queen Elizabeth University Hospital campus. This highlighted the importance of the Imaging Centre of Excellence as a key part of the Scottish Precision Medicine ecosystem. |
| Year(s) Of Engagement Activity | 2016 |
| Description | Wellcome Trust |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Third sector organisations |
| Results and Impact | Overview of University of Glasgow's investment in academic infrastructure for innovation and collaboration with industry and the NHS at the Queen Elizabeth University Hospital campus and Scotland's Precision Medicine Ecosystem. Tour of facilities |
| Year(s) Of Engagement Activity | 2019 |
| Description | Wellcome Trust visit Anne-Marie Corriat |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Visit and discussion with Dr Coriat - raising awareness of Imaging Centre in context of her role as Head of Research Careers Wellcome Trust |
| Year(s) Of Engagement Activity | 2017 |